Viatris (VTRS) Net Margin Growth (1y) (2020 - 2026)
Powered by 
Analysis
Viatris (VTRS) Net Margin Growth (1y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | -2,064.00 |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | -303.00 |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | -1,110.00 |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 383.00 |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 406.00 |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -10,766.00 |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 543.00 |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | -129.00 |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | 4,369.00 |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -303.00 |
| Mar 31, 2026 | 9,849.00 |
| Dec 31, 2025 | 546.00 |
| Sep 30, 2025 | -594.00 |
| Jun 30, 2025 | 847.00 |
| Mar 31, 2025 | -9,659.00 |
| Dec 31, 2024 | 531.00 |
| Sep 30, 2024 | -588.00 |
| Jun 30, 2024 | -1,533.00 |
| Mar 31, 2024 | -292.00 |
| Dec 31, 2023 | -4,604.00 |
| Sep 30, 2023 | -28.00 |
| Jun 30, 2023 | -89.00 |
| Mar 31, 2023 | -350.00 |
| Dec 31, 2022 | 3,216.00 |
| Sep 30, 2022 | 182.00 |
| Jun 30, 2022 | 1,372.00 |
| Mar 31, 2022 | 3,294.00 |
| Dec 31, 2021 | 1,920.00 |
| Mar 31, 2021 | -2,421.00 |